| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $682K | — | — |
| Cost of Revenue | $452K | — | — |
| Gross Profit | $230K | — | — |
| R&D Expense | $47K | — | +45.1% |
| SG&A Expense | $1.4M | — | +561.0% |
| Interest Expense | $184K | — | — |
| Net Income | -$5.0M | — | -208.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $733K | +28.2% | +31.6% |
| Accounts Receivable | $428K | +74.4% | — |
| Inventory | $254K | +166.6% | — |
| Current Assets | $16.4M | +138.5% | +140.4% |
| Total Assets | $26.0M | +102.3% | +192.9% |
| Current Liabilities | $11.3M | +186.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.0M | — | -121.1% |
| Capital Expenditures | $363K | — | — |
| Investing Cash Flow | -$2.5M | — | -1053.5% |
| Financing Cash Flow | $14.4M | — | +389.7% |
| Free Cash Flow | -$3.3M | — | — |
| +1386.0% |
| Total Liabilities | $13.4M | +166.9% | +1666.1% |
| Stockholders' Equity | $12.6M | +60.9% | +55.1% |